Physician's Weekly1d
Repeated N-Antigen Antibody Monitoring for Assessing SARS-CoV-2 Exposure
CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...
Antigenic variation: How pathogens control changes in their cell surface to evade the immune system
The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the ...
Hoodline9d
Vanderbilt's High-Tech Quest for the Holy Grail of Antibody Therapy, $30M ARPA-H Grant Catapults AI Revolution in Disease Treatment
VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...
Vanderbilt to experiment with AI to develop therapeutic antibodies
Vanderbilt University Medical Center has been awarded up to $30 million by the Advanced Research Projects Agency for Health ...
News Medical on MSN11d
VUMC to develop AI technology for therapeutic antibody discovery
An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence ...
Science Daily4d
Antigenic variation: Decoding the mechanism controlling antigen activation in trypanosomes
The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the pathogen, thus marking it as an intruder and triggering an immune response. For ...